Evidence map›Paper›PMID 1370531›Full record

ArticleThe Journal of experimental medicine1992

Phospholipase C-gamma 1 association with CD3 structure in T cells.

J D Dasgupta, C Granja, B Druker, L L Lin, E J Yunis, V Relias

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 1992. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Cyclosporin A inhibits CD40 ligand expression in T lymphocytes.The Journal of clinical investigation · 1994
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

J D DasguptaDivision of Immunogenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115.
C Granja
B Druker
L L Lin
E J Yunis
V Relias
Dana-Farber Cancer Institute · USPfizer (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently, we and others have reported tyrosine phosphorylation of phospholipase C-gamma 1 (PLC gamma 1) enzyme after CD3 activation of T cells, and have proposed that PLC gamma 1 mediates signal transduction through the T cell receptor (TCR/CD3). Here, using immunoblotting and immune complex PLC assays, we show that CD3 stimulation of Jurkat cells induces the association of PLC gamma 1 enzyme with CD3 complex. PLC activity is also found to co-precipitate with the CD3 zeta chain from activated cells. In addition, in vitro PLC assays show that CD3 activation leads to about 10-fold stimulation of PLC gamma 1 activity. These results, along with the observation that Jurkat cells preferentially express PLC gamma 1, indicate that PLC gamma 1 participates in CD3 signaling.

Indexed as

Antigens, Differentiation, T-LymphocyteCD3 ComplexCell LineHumansImmunoblottingKineticsMacromolecular SubstancesPhosphotyrosineReceptors, Antigen, T-CellT-LymphocytesType C PhospholipasesTyrosineAntigens, Differentiation, T-LymphocyteCD3 ComplexMacromolecular SubstancesPhosphotyrosineReceptors, Antigen, T-CellType C PhospholipasesTyrosine

Identifiers

PMID1370531
PMCPMC2119075
OpenAlexW2062768849

What Socratic holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.